glp-1 compounding crackdown news october 2025 FDA is moving to restrict mass-marketed compounded products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified FDA telehealth crackdown highlights role

Xiao-Yun X, Zhao-Hui M, Ke C, Hong-Hui H, Yan-Hong X

But no medication is for everyone, including GLP-1 drugs

Common GLP-1 Medications Explained Several GLP-1 medications are approved for use in the United States, including: Ozempic (semaglutide) Wegovy (also semaglutide, prescribed for weight management), Trulicity (dulaglutide) Victoza (liraglutide) These are available as weekly or daily injections and have seen a surge in demand, as new studies validate not just their effectiveness for diabetes but also for aiding weight loss

Mounjaro and Wegovy vs

Nutrition matters more than ever While GLP-1 drugs suppress appetite, they also create new nutritional challenges

Some analyses also suggest an increased risk of biliary disease, particularly cholelithiasis, with GLP-1RA therapy